Product information and disease descriptionProduct descriptionProduct information
Dosage forms and strengths
6 evidence topics · 4 sources
Investigational dosage form: 400 mg film-coated immediate-release tablet
Tablets per daily dose in NATiV3: two or three 400 mg tablets
Packaging of the investigational tablets: HDPE bottles
Storage and stability of the investigational tablets
Bioequivalence study in healthy volunteers, France, February to May 2026
Commercial strengths and package sizes
No evidence found.